Cost-benefit analysis of a new alcohol biomarker, carbohydrate deficient transferrin, in a chronic illness primary care sample

Kathryn Sullivan Dillie, Marlon Mundt, Michael T. French, Michael F. Fleming

Research output: Contribution to journalArticle

17 Scopus citations

Fingerprint Dive into the research topics of 'Cost-benefit analysis of a new alcohol biomarker, carbohydrate deficient transferrin, in a chronic illness primary care sample'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds